From the publishers of JADPRO

Metastatic Triple-Negative Breast Cancer Resource Center

Advertisement

Immunotherapy Toxicity: Identification and Management

Last Updated: Tuesday, March 7, 2023

Using data from recent clinical trials, this review focuses on known immune-related adverse events, particularly those seen in patients with breast cancer, and will summarize their prevalence, severity, and outcomes. The authors discuss optimal strategies for early recognition and management, as well as approaches toward cautious retreatment following the resolution of immune-related adverse events.

Breast Cancer Research and Treatment
Advertisement
News & Literature Highlights
Advertisement
Advertisement